Giustina, Andrea
Uygur, M. M.
Frara, S.
Barkan, A.
Biermasz, N. R.
Chanson, P.
Freda, P.
Gadelha, M.
Haberbosch, L.
Kaiser, U. B.
Lamberts, S.
Laws, E.
Nachtigall, L. B.
Popovic, V.
Reincke, M.
van der Lely, A. J.
Wass, J. A. H.
Melmed, S.
Casanueva, F. F.
Article History
Accepted: 26 April 2024
First Online: 4 June 2024
Declarations
:
: A. Giustina is a Consultant for Ipsen, Pfizer, and Recordati, and received Research Grants to Institutions from, Pfizer. M.M. Uygur received a Grant from Pfizer. S. Frara received consultancy and speaker fees from Ipsen, Pfizer, Novartis, and Recordati. A.J. van der Lely received consultancy and/ or speakers’ fees from Amoly Pharma SA, Dexel, Cambian, Crinetics, Ipsen, and Pfizer. S. Melmed is a Consultant for Ionis, Ipsen, and Novo Nordisk and receives a Research Grant from Recordati. Other authors do not declare any competing interest.